Actively Recruiting

Phase Not Applicable
Age: 60Years - 80Years
All Genders
ID07042087

Lifestyle for the BRAin Health - Time Restricted Eating and Mindfulness

Led by St. Anne's University Hospital Brno, Czech Republic · Updated on 2025-06-27

48

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

S

St. Anne's University Hospital Brno, Czech Republic

Lead Sponsor

S

Slovak Academy of Sciences

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying the effects of a 9-month lifestyle intervention on older adults aged 60 to 80 who are at increased risk of developing Alzheimer's disease. The trial compares two groups: one combining yoga-based mindfulness techniques with time-restricted eating, and the other receiving cognitive training with stretching. The goal is to assess changes in cognitive function, plasma markers of neurodegeneration such as tau protein, physical fitness, and metabolism. Participants in the first group will attend twice-weekly 90-minute sessions of yoga, including physical postures, breathing exercises, and meditation, alongside following a time-restricted eating schedule with nutritional counseling promoting a flexitarian diet. The second group will engage in twice-weekly 90-minute sessions of cognitive training targeting memory, attention, executive function, and social skills, paired with guided stretching exercises led by therapists. Both interventions last for nine months and are designed to evaluate different approaches to brain health. During the study, participants will have their cognitive function and plasma biomarkers measured at the start and end of the nine months. Additional assessments include computerized cognitive tests, depression and anxiety scales, adherence monitoring, and quality of life questionnaires. This comprehensive evaluation allows researchers to understand the impact of these lifestyle interventions on brain health and overall well-being in older adults at risk of Alzheimer's disease.

CONDITIONS

Brief Title

Lifestyle for the BRAin Health - Time Restricted Eating and Mindfulness

Who Can Participate

Age: 60Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 60 to 80 years
  • Diagnosis of Subjective Cognitive Impairment (SCI) or Mild Cognitive Impairment (MCI)
  • Mini-mental-scale (MMSE) score between 24 and 30
  • Positive plasma pTau217 biomarker
  • Stable dose of iAChE therapy if applicable
  • Ability to participate in a 9-month intervention
Not Eligible

You will not qualify if you...

  • Stroke or myocardial infarction within the past year
  • Decompensated internal conditions such as severe heart failure, kidney failure, unstable diabetes, or GLP1 agonist therapy
  • Long-term psychiatric treatment except well-managed depression
  • Neurological conditions affecting mobility or cognition like Parkinson's disease, severe tremor, or epilepsy
  • Severe sensory or motor impairment preventing participation
  • Active cancer treated within the past 5 years
  • Poor anticipated compliance due to transport, time constraints, or non-cooperation
  • Concurrent participation in another clinical study
  • Unstable iAChE medication regimen
  • Substance or alcohol dependence

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 9 months

Participants engage in a 9-month intervention consisting of either yoga-based mindfulness sessions combined with time-restricted eating, or cognitive training combined with guided stretching. Sessions occur twice weekly for 90 minutes each, focusing on improving cognitive function, physical fitness, and metabolic health.

Twice-weekly sessions for 9 months

Trial Site Locations

Total: 1 location

1

Fnusa/ Icrc

Brno, Czechia, 64400

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Comparison of Cardiac [18F]-MFBG PET Versus [123I]-MIBG SPEC...

Parkinson Disease

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here